IMA Q1 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-2.6% YoY

Gross Profit

-$11M-323.8% margin

Operating Income

-$17M-501.2% margin

Net Income

-$17M-497.6% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

-83.3%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$228M

Total Liabilities

$35M

Stockholders' Equity

$193M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-2.6%
Gross Profit	-$11M	-$7M	-67.4%
Operating Income	-$17M	-$10M	-74.5%
Net Income	-$17M	-$10M	-73.3%